Advertisement
Advertisement
U.S. Markets close in 6 hrs 23 mins
Advertisement
Advertisement
Advertisement
Advertisement

Amyris, Inc. (AMRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.00-0.09 (-1.48%)
As of 09:37AM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close6.09
Open6.21
Bid0.00 x 3200
Ask0.00 x 1200
Day's Range5.88 - 6.16
52 Week Range3.07 - 23.42
Volume405,603
Avg. Volume5,128,849
Market Cap1.773B
Beta (5Y Monthly)1.44
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • TipRanks

    3 “Strong Buy” Stocks Under $10 That Are Poised for a Breakout Year

    2021 has been a fantabulous year for stock investors, with the S&P 500 returning 25% year to date. But here’s the bad news: all good things must come to an end, and the clock’s ticking down to the end of 2021. But here’s the good news, too: 2022 might also be not too shabby a year for stocks. Most of Wall Street’s pros believe we’ll see between 8% and 12% growth going forward. That’s a sound return, and in line with the market’s long-term overall gains. What investors need to do now is optimize

  • Motley Fool

    Why Shares of Amyris Are Plummeting This Week

    Consistent with the falling temperatures outside, investors are turning a cold shoulder to synthetic biology specialist Amyris (NASDAQ: AMRS) this week. As of the close of the trading session on Thursday, shares of Amyris have plunged 47% from their closing price of $14.09 last Friday. Beginning the week on an inauspicious note, Amyris reported third-quarter 2021 earnings after the market closed on Monday.

  • Motley Fool

    Why Shares of Amyris Are Getting Crushed Today

    Failing to deliver on both the top and bottom lines, synthetic-biology specialist Amyris (NASDAQ: AMRS) reported disappointing third-quarter 2021 earnings results yesterday after the market closed. In addition, investors are selling shares after learning that the company is raising capital through the issuance of senior convertible notes. Although the company reported a year-over-year sales increase of 39.7%, it didn't seem to be enough to satisfy investors' appetites.

Advertisement
Advertisement